| Id |
Subject |
Object |
Predicate |
Lexical cue |
| T1 |
0-168 |
Sentence |
denotes |
Combination of polymorphisms within 5' and 3' untranslated regions of thymidylate synthase gene modulates survival in 5 fluorouracil-treated colorectal cancer patients. |
| T2 |
169-359 |
Sentence |
denotes |
In the present study we explored the effect of three polymorphisms of the TS gene on overall and progression- free survival of colorectal cancer (CRC) patients subjected to 5FU chemotherapy. |
| T3 |
360-507 |
Sentence |
denotes |
A 28 bp variable number of tandem repeats (VNTR), a G/C single nucleotide polymorphism (SNP), and a deletion of 6 bp at position 1494 were studied. |
| T4 |
508-619 |
Sentence |
denotes |
The possible combined effect of these DNA polymorphisms on the clinical outcome of patients was also evaluated. |
| T5 |
620-732 |
Sentence |
denotes |
A retrospective study was carried out on paraffin-embedded sections from 113 patients diagnosed of advanced CRC. |
| T6 |
733-899 |
Sentence |
denotes |
TS genotyping methods were polymerase chain reaction (PCR) for VNTR and PCR, followed by restriction length fragment polymorphism (PCR-RFLP) for SNP and ins/del 6 bp. |
| T7 |
900-1109 |
Sentence |
denotes |
To study the combined effect of TS polymorphisms, four categories were defined accordingly to the level of expression attributed to SNP and ins/del 6 bp genotypes: C&allele 6-, C&6+/6+, G&allele6- and G&6+/6+. |
| T8 |
1110-1177 |
Sentence |
denotes |
VNTR and ins/del 6 bp genotypes varied with tumour anatomical site: |
| T9 |
1178-1347 |
Sentence |
denotes |
2R/2R genotype was rare in left-sided tumours (7.0% vs. 26.3% of right-sided and 24.1% of rectal cancers; P<0.01), where the variant allele 6- was very frequent (69.0%). |
| T10 |
1348-1445 |
Sentence |
denotes |
Instead, most patients with right-sided tumours were wild-type homozygous 6+/6+ (63.9%) (P<0.01). |
| T11 |
1446-1566 |
Sentence |
denotes |
Heterozygous 6+/6- genotype was more frequent among tumours classified as C (50.0%) and D (76.5%) Dukes stages (P=0.05). |
| T12 |
1567-1659 |
Sentence |
denotes |
None of the studied polymorphisms alone affected overall or progression-free survival (PFS). |
| T13 |
1660-1937 |
Sentence |
denotes |
C&6+/6+ and G&6+/6+ combined genotypes were respectively associated to the best and worst PFS (P=0.03 when compared with each other), while combinations carrying the allele 6- determined an intermediate evolution that might be indicative of a variable response to chemotherapy. |
| T14 |
1938-2059 |
Sentence |
denotes |
The rate of Dukes B stage tumours was unexpectedly high (59.1%) among patients with the unfavourable G&6+/6+ combination. |
| T15 |
2060-2198 |
Sentence |
denotes |
In our study the combination of high TS expression genotypes G&6+/6+ identifies a group of high risk within CRC patients treated with 5FU. |